The different effects of the FCGR2A gene in SLE and KD suggest that development of KD is due to insufficient B cell immunity, whereas development of SLE is due to autoimmune activation (activation of B cell immunity). The gene discussed is FCGR2A; the disease is systemic lupus erythematosus.